Celltrion, Stock Price +3.19% at This Time... 1,227,476 Shares Net Bought by Individuals in the Last 5 Days

As of 12:30 PM on the 18th, Celltrion is trading at 339,500 KRW, up 3.19% from the previous day. The trading volume is 1,294,509 shares, which is 39.19% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On January 18, researcher Han Byunghwa of Eugene Investment & Securities stated, "Success in Phase 2 of the COVID-19 antibody treatment, sufficient for emergency approval overseas. Emergency approval and exports abroad are expected to occur simultaneously in the second quarter. Celltrion has demonstrated the capability to compete with global big pharma in a short period. Repeated pandemics will enable Celltrion to develop a second Regkirona injection and possess two growth engines in the new drug and biosimilar markets. The definite fact is that Celltrion has shown development capabilities on par with global big pharma." He set Celltrion's target price at 400,000 KRW.

Over the past five days, individual investors have net purchased 1,227,476 shares of Celltrion, while foreigners and institutions have net sold 653,039 shares and 621,189 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.